Alzheimer's & Dementia News and Research

Latest Alzheimer's & Dementia News and Research

Young stroke patients who have seizures are at increased risk for developing dementia

Young stroke patients who have a seizure following their diagnosis are two and a half times more likely to develop dementia than patients who don't experience seizures, according to a new study by Penn State College of Medicine researchers.

14 Jul 2022

What is the association between long-term salt usage behavior and risk of premature mortality?

Researchers assessed the impact of increased salt consumption on life expectancy.

14 Jul 2022

Few people may have symptoms of depression years before their stroke, finds study

While depression is a common problem for people who have had a stroke, some people may have symptoms of depression years before their stroke, according to a study published in the July 13, 2022, online issue of Neurology®, the medical journal of the American Academy of Neurology.

14 Jul 2022

People with non-alcoholic fatty liver disease may have higher risk of dementia

People who have non-alcoholic fatty liver disease, a buildup of fat cells in the liver, may have a higher risk of dementia, according to a new study published in the July 13, 2022, online issue of Neurology®, the medical journal of the American Academy of Neurology.

13 Jul 2022

New chemical biological tools could help better understand the progression of Parkinson's disease

Researchers are a step closer to understanding how Parkinson's disease develops and progresses thanks to chemical biological tools developed at Simon Fraser University.

13 Jul 2022

Age-related increases in brain inflammation may link Alzheimer's disease risk with sleep disturbance

A multisite research team from the University of California, Irvine, the University of Wisconsin–Madison and Wake Forest University has discovered that brain inflammation may link Alzheimer's disease risk with sleep disturbance, which may aid early detection and prevention efforts by identifying novel treatment targets at preclinical stages.

13 Jul 2022

New center aims to accelerate research into biomarkers of neurodegenerative diseases

A new center established at Washington University School of Medicine in St. Louis aims to accelerate research into biomarkers of neurodegenerative conditions such as Huntington's and Parkinson's diseases, amyotrophic lateral sclerosis (ALS), multiple sclerosis (MS) and the so-called tauopathies, a group that includes Alzheimer's disease along with rarer diseases such as frontotemporal dementia, corticobasal syndrome and progressive supranuclear palsy.

13 Jul 2022

Lifestyle factors may be more important than age in determining a person's cognitive function

Individuals with no dementia risk factors, such as smoking, diabetes or hearing loss, have similar brain health as people who are 10 to 20 years younger than them, according to a new Baycrest study. The study found that a single dementia risk factor could reduce cognition by the equivalent of up to three years of aging.

13 Jul 2022

Diversifying STEM; the Importance of Representation, Equity, and Inclusion

As part of our SLAS Europe 2022 coverage, we speak to Paula Petrone, Associate Research Professor at ISGlobal, about the importance of representation, inclusion, and equity in the STEM fields.

From Society for Laboratory Automation and Screening (SLAS) 13 Jul 2022

What is the association between PASC-AMs and the diagnosis of new-onset psychiatric illness after acute SARS-CoV-2 infections?

Researchers investigated if non-psychiatric PASC-AMs increase the risk of new-onset psychiatric illness diagnosis.

12 Jul 2022

New computational model can detect cognitive impairment from audio recordings of neuropsychological tests

It takes a lot of time-;and money-;to diagnose Alzheimer's disease. After running lengthy in-person neuropsychological exams, clinicians have to transcribe, review, and analyze every response in detail.

11 Jul 2022

Scientists uncover how the innate immune system detects and fights HIV-1

Human immunodeficiency virus 1, more commonly known as HIV-1, is known for its uncanny ability to evade the immune system.

8 Jul 2022

Researchers unravel the functioning of antibodies in autoimmune encephalitis

Using a state-of-the-art method, researchers at DZNE and the University of Texas have succeeded for the first time at unraveling the effects of autoimmune antibodies, that are directed against the brain, in detail at the atomic level.

8 Jul 2022

Study shows how tau protein, critical to Alzheimer's, turns from normal to diseased state

Alzheimer’s disease, the most common form of dementia, currently has no cure or effective therapy, in part due to gaps in our understanding of how the progressive neurodegenerative disorder arises in the brain.

8 Jul 2022

New non-invasive treatment for patients suffering from treatment-resistant depression and dementia

A joint research team from the LKS Faculty of Medicine, The University of Hong Kong (HKUMed) and City University of Hong Kong (CityU) has discovered that the electrical stimulation of the eye surface can alleviate depression-like symptoms and improve cognitive function in animal models.

8 Jul 2022

Fatty foods may expand waistline and cause havoc to the brain

New research shows that fatty foods may not only be adding to your waistline but also playing havoc with your brain.

8 Jul 2022

New biosensor system derived from E. coli bacteria could accelerate drug development

For more affordable, sustainable drug options than we have today, the medication we take to treat high blood pressure, pain or memory loss may one day come from engineered bacteria, cultured in a vat like yogurt.

7 Jul 2022

COVID-19 was the third leading cause of death in the US in 2020 and 2021

In a recent article published in the journal JAMA Internal Medicine, investigators examined the major causes of mortality across the United States (US) in the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic.

7 Jul 2022

DZNE and Intravacc receive € 2.5 million EU funding to develop a prototype ALS vaccine

DZNE and Intravacc B.V., a world leading contract development and manufacturing organization (CDMO) of preventive and therapeutic vaccines, have been awarded a funding of € 2.5 million from the European Union (EIC Transition Grant) to further develop a prototype ALS vaccine, including process development, scale-up, and toxicology study.

6 Jul 2022

Noradrenergic drugs could be repurposed to offer effective treatment for Alzheimer's disease symptoms

There is "good evidence" that drugs to treat attention deficit hyperactivity disorder (ADHD) might also successfully treat key aspects of Alzheimer's disease, finds a pooled data analysis of the available research, published online in the Journal of Neurology Neurosurgery & Psychiatry.

6 Jul 2022

Alzheimer's & Dementia News and Research

Latest Alzheimer's & Dementia News and Research

Young stroke patients who have seizures are at increased risk for developing dementia

What is the association between long-term salt usage behavior and risk of premature mortality?

Few people may have symptoms of depression years before their stroke, finds study

People with non-alcoholic fatty liver disease may have higher risk of dementia

New chemical biological tools could help better understand the progression of Parkinson's disease

Age-related increases in brain inflammation may link Alzheimer's disease risk with sleep disturbance

New center aims to accelerate research into biomarkers of neurodegenerative diseases

Lifestyle factors may be more important than age in determining a person's cognitive function

Diversifying STEM; the Importance of Representation, Equity, and Inclusion

What is the association between PASC-AMs and the diagnosis of new-onset psychiatric illness after acute SARS-CoV-2 infections?

New computational model can detect cognitive impairment from audio recordings of neuropsychological tests

Scientists uncover how the innate immune system detects and fights HIV-1

Researchers unravel the functioning of antibodies in autoimmune encephalitis

Study shows how tau protein, critical to Alzheimer's, turns from normal to diseased state

New non-invasive treatment for patients suffering from treatment-resistant depression and dementia

Fatty foods may expand waistline and cause havoc to the brain

New biosensor system derived from E. coli bacteria could accelerate drug development

COVID-19 was the third leading cause of death in the US in 2020 and 2021

DZNE and Intravacc receive € 2.5 million EU funding to develop a prototype ALS vaccine

Noradrenergic drugs could be repurposed to offer effective treatment for Alzheimer's disease symptoms

eBook: Neurodegeneration Therapeutics Discovery eBook

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Alzheimer's & Dementia News and Research

Latest Alzheimer's & Dementia News and Research

eBook: Neurodegeneration Therapeutics Discovery eBook

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in